Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: A retrospective cohort study

As it has been shown that lopinavir (LPV) and hydroxychloroquine (HCQ) have in vitro activity against coronaviruses, they were used to treat COVID‐19 during the first wave of the epidemic in Lombardy, Italy. To compare the rate of clinical improvement between those who started LPV/ritonavir (LPV/r)+...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Med Virol
Hauptverfasser: Giacomelli, Andrea, Pagani, Gabriele, Ridolfo, Anna L., Oreni, Letizia, Conti, Federico, Pezzati, Laura, Bradanini, Lucia, Casalini, Giacomo, Bassoli, Cinzia, Morena, Valentina, Passerini, Simone, Rizzardini, Giuliano, Cogliati, Chiara, Ceriani, Elisa, Colombo, Riccardo, Rusconi, Stefano, Gervasoni, Cristina, Cattaneo, Dario, Antinori, Spinello, Galli, Massimo
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Research Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7436522/
https://ncbi.nlm.nih.gov/pubmed/32776534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26407
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge